Topics

Zydelig® Combinations Continue to Improve Survival in Recurrent CLL

12:25 EDT 28 Apr 2019 | Cancer Connect

Zydelig® Combined with Treanda and Rituxan Appears Promising in Treatment of Chronic Lymphocytic Leukemia

Original Article: Zydelig® Combinations Continue to Improve Survival in Recurrent CLL

NEXT ARTICLE

More From BioPortfolio on "Zydelig® Combinations Continue to Improve Survival in Recurrent CLL"

Quick Search